Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
NCT ID: NCT06558461
Last Updated: 2024-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
140 participants
INTERVENTIONAL
2022-06-01
2024-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
NCT01276821
Comparison of 3% Hypertonic Saline and Salbutamol in Children With Bronchiolitis
NCT06665711
Hypertonic Saline for Acute Bronchiolitis
NCT01247064
Nebulized Hypertonic Saline for Bronchiolitis
NCT01460524
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department
NCT01660867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3% hypertonic saline
Children will receive standard medical care coordinating with nebulizing 3% hypertonic saline in the treatment of bronchiolitis. They received 4ml of 3% Sodium chloride, nebulized three times daily until discharge.
3% Sodium Chloride
4ml nebulized three times daily
Control
Children will only receive standard medical care.
Standard care
Standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3% Sodium Chloride
4ml nebulized three times daily
Standard care
Standard care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe respiratory failure required mechanical ventilation.
* The patient left on his own during treatment.
1 Month
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Can Tho University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Van VuTuong Le, MD
Role: PRINCIPAL_INVESTIGATOR
Can Tho University of Medicine and Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Can Tho Children's Hospital
Can Tho, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.